中關村科技

Beijing Centek Development (Holding) Co., Ltd. (abbreviated as Centek) was established in 1999 and listed on the Shenzhen Stock Exchange. Its business layout has gradually shifted from "technology real estate + pharmaceuticals" toward a development and operating strategy centered on "pharmaceutical and health." In August 2018, its industry classification was changed from "comprehensive" to "pharmaceutical manufacturing." In August 2021, the company adjusted its development strategy to further focus its positioning and planned to build an innovative pharmaceutical industry group focused on pharmaceuticals. In July 2024, it further adjusted its development strategy, committing to becoming a leading pharmaceutical and health industry service provider. The company operates across four major segments: pharmaceuticals, medical care and elderly care, health products, and investment, with more than ten subsidiaries. Its pharmaceutical segment covers APIs, traditional Chinese medicine, chemical drugs, and biological drugs, and is an innovative pharmaceutical group integrating R&D, production, and marketing. Its health products business aims to become a leading domestic professional service supplier for dental clinics. Its medical care and elderly care segment aims to build an influential domestic health and elderly care industry group through standardized chain operations. Its investment business invests in many fields through controlling and minority stakes, contributing investment income to the listed company and shareholders.

Beijing Centek Development (Holding) Co., Ltd. (abbreviated as Centek) was established in 1999 and listed on the Shenzhen Stock Exchange. In 2015, its industrial layout gradually shifted from "technology real estate + pharmaceuticals" to a development and operating strategy centered on "pharmaceutical and health." In August 2018, the company received regulatory recognition, and its industry classification was changed from "comprehensive" to "pharmaceutical manufacturing," marking the initial success of its strategic transformation. In August 2021, the company adjusted its development strategy to further focus its positioning and planned to build an innovative pharmaceutical industry group focused on pharmaceuticals. In July 2024, the company further adjusted its development strategy, committing to becoming a leading pharmaceutical and health industry service provider. Through rapid development in recent years, Centek has more than ten high-quality enterprises across four major segments: pharmaceuticals, medical care and elderly care, health products, and investment.

• Huasu Pian (西地碘含片)

• Feisaile (盐酸苯环壬酯片)

• Bosu

• Yuanzhi (盐酸贝尼地平片)

• Yuantan (格列吡嗪分散片)

• Wujia Biochemical Capsules

• Huasu Yuchuang oral care products

• Huasu Qingqing toothpaste

• Huasu Hebei children's toothpaste

• Yaya Weishi

1. 1北京中关村科技发展（控股）股份有限公司centek.com.cn
2. 2关于我们 - 北京中关村科技发展（控股）股份有限公司centek.com.cn
3. 3健康 - 北京中关村科技发展（控股）股份有限公司centek.com.cn
4. 4医药 - 北京中关村科技发展（控股）股份有限公司centek.com.cn